Concepedia
Statistics
Publications
6
Citations
148
H-Index
Active since
2008
Affiliations
Biocon (India)(Current)
Bristol-Myers Squibb (India)
Syngene International (India)
Bharathidasan University
Bristol-Myers Squibb (United States)
Prakash Anjanappa is an author at Biocon (India) specializing in ammonia synthesis, catalyst preparation, and organic chemistry.
Publications per year
2008–2021
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate
Robert J. Cherney, Prakash Anjanappa, K. Selvakumar et al. · ACS Medicinal Chemistry Letters · 2021 · 41 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +14
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies
Kap‐Sun Yeung, Brett R. Beno, Kyle Parcella et al. · Journal of Medicinal Chemistry · 2017 · 31 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Efficient indoles and anilines syntheses employing tert-butyl sulfinamide as ammonia surrogate
Prakash Anjanappa, Dibakar Mullick, Kumaravel Selvakumar et al. · Tetrahedron Letters · 2011 · 29 citations
Natural Sciences, Chemistry, Medicinal Chemistry +8
2-(Trimethylsilyl)ethanesulfonyl amide as a new ammonia equivalent for palladium-catalyzed amination of aryl halides
Prakash Anjanappa, Dibakar Mullick, Kumaravel Selvakumar et al. · Tetrahedron Letters · 2008 · 26 citations
Natural Sciences, Chemistry, Catalysis +10
Carbamic acid 2-trimethylsilylethyl ester as a new ammonia equivalent for palladium-catalyzed amination of aryl halides
Dibakar Mullick, Prakash Anjanappa, Kumaravel Selvakumar et al. · Tetrahedron Letters · 2010 · 11 citations
Natural Sciences, Chemistry, Catalysis +8
1–5 of 6